Drug Use Investigation on Zithromac Tablets 600mg in HIV Patients (Post Marketing Commitment Plan).

Trial Profile

Drug Use Investigation on Zithromac Tablets 600mg in HIV Patients (Post Marketing Commitment Plan).

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2013

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; HIV infections
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jun 2012 Actual patient number is 447 according to ClinicalTrials.gov.
    • 26 Jun 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top